Follow
Emilio CORTES SANCHEZ
Emilio CORTES SANCHEZ
Huntsman Cancer Institute
Verified email at hci.utah.edu
Title
Cited by
Cited by
Year
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
KP Guillen, M Fujita, AJ Butterfield, SD Scherer, MH Bailey, Z Chu, ...
Nature cancer 3 (2), 232-250, 2022
1712022
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ...
Nature genetics 53 (1), 86-99, 2021
1512021
PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
TH Truong, EA Benner, KM Hagen, NA Temiz, CP Kerkvliet, Y Wang, ...
Oncogene 40 (25), 4384-4397, 2021
212021
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer
ER Polanco, TE Moustafa, A Butterfield, SD Scherer, E Cortes-Sanchez, ...
Communications Biology 5 (1), 794, 2022
122022
Breast cancer PDxO cultures for drug discovery and functional precision oncology
SD Scherer, L Zhao, AJ Butterfield, CH Yang, E Cortes-Sanchez, ...
STAR protocols 4 (3), 102402, 2023
32023
Micro-organospheres: An automated patient-derived model platform for rapid drug screening of breast cancer.
Z Wang, E Cortes-Sanchez, CH Yang, D Nelson, D Delubac, SD Hsu, ...
Journal of Clinical Oncology 39 (15_suppl), e12628-e12628, 2021
32021
New approaches for new antibiotics
E Cortes-Sanchez, PA Hoskisson
The Biochemist 37 (3), 28-31, 2015
22015
Determinants of birinapant efficacy in triple negative breast cancer
EA Brown, CH Yang, E Cortes-Sanchez, Z Chu, J Govindharajulu, ...
Cancer Research 83 (7_Supplement), 393-393, 2023
2023
1149P An automated platform for rapid drug screening in patient-derived micro-organospheres
Z Wang, E Cortes-Sanchez, CH Yang, D Nelson, C Keating, A Smith, ...
Annals of Oncology 32, S929, 2021
2021
Steroid receptor co-activators regulate metabolic kinases to drive therapy resistant ER+ breast cancer
TH Truong, E Benner, KM Hagen, NA Temiz, CP Kerkvliet, Y Wang, ...
Cancer Research 81 (13_Supplement), 3085-3085, 2021
2021
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ...
Nature genetics 53 (5), 761-761, 2021
2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts (vol 53, pg 86, 2021)
XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ...
NATURE GENETICS 53 (5), 761-761, 2021
2021
A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology
KP Guillen, M Fujita, AJ Butterfield, SD Scherer, MH Bailey, Z Chu, ...
bioRxiv, 2021.02. 28.433268, 2021
2021
Co-inhibition of autophagy and MAPK signaling in RAS-driven cancers
M Foth, C Kinsey, S Schuman, B Battistone, EC Sanchez, D Kircher, ...
Cancer Research 80 (16_Supplement), 1225-1225, 2020
2020
PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer
TH Truong, EA Benner, KM Hagen, NA Temiz, CP Kerkvliet, Y Wang, ...
bioRxiv, 2020.08. 07.238550, 2020
2020
A synthetic biology approach to the biosynthesis of novel pyrrole-amide antibiotics
AE Cortés Sánchez
2016
Tailoring Streptomyces: producing novel minor groove binder antibiotics
EC Sanchez, S De Ornellas, J May, G Burley, P Hoskisson
New Biotechnology, S67, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–17